AF
BPMC

Allworth Financial’s Blueprint Medicines BPMC Stock Holding History

Allworth Financial’s Portfolio BPMC Stock Details BPMC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-121
Closed -$15.5K – 4924
2025
Q2 		$15.5K Buy
121
+74
+157% +$7.69K ﹤0.01% 2672
2025
Q1 		$4.05K Buy
47
+33
+236% +$3.22K ﹤0.01% 2877
2024
Q4 		$1.56K Buy
14
+10
+250% +$916 ﹤0.01% 3240
2024
Q3 		$370 Hold
4
– – ﹤0.01% 3484
2024
Q2 		$460 Hold
4
– – ﹤0.01% 3391
2024
Q1 		$380 Hold
4
– – ﹤0.01% 3355
2023
Q4 		$369 Buy
4
+2
+100% +$130 ﹤0.01% 3194
2023
Q3 		$101 Sell
2
-6
-75% -$321 ﹤0.01% 3343
2023
Q2 		$506 Buy
+8
New +$435 ﹤0.01% 2899
2022
Q4 		– Sell
-193
Closed -$13K – 3025
2022
Q3 		$13K Buy
+193
New +$12.4K ﹤0.01% 1469
2022
Q2 		– Sell
-4
Closed – – 2412
2022
Q1 		$0 Buy
+4
New +$287 ﹤0.01% 2127
2020
Q1 		– Sell
-341
Closed -$27K – 1231
2019
Q4 		$27K Buy
+341
New +$25.5K ﹤0.01% 461

Other funds holding BPMC

DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Allworth Financial's BPMC Position: Q3 2025 in Review

Allworth Financial sold out of Blueprint Medicines (BPMC) in Q3 2025, closing a stake of 121 shares — an estimated $15.5K sold.

Allworth Financial first reported a position in BPMC in Q4 2019 and held it in 12 quarters. The position peaked at $27K in Q4 2019. 5 funds tracked by Wall St. Rank hold BPMC as of Q3 2025.

  • Allworth Financial reported no remaining Blueprint Medicines position as of Q3 2025 after selling out during the quarter.
  • Allworth Financial sold 121 Blueprint Medicines shares in Q3 2025, an estimated $15.5K.
  • Allworth Financial first reported a position in Blueprint Medicines in Q4 2019 and held it in 12 quarters.
  • Allworth Financial's Blueprint Medicines position peaked at $27K in Q4 2019.
  • 5 funds tracked by Wall St. Rank held Blueprint Medicines as of Q3 2025.

Based on Allworth Financial's 13F filing for Q3 2025, filed 2 Dec 2025.